Table 3.
Correlation between the clinical characteristics and Sp1 expression in NPC patients
| Characteristics |
Sp1 |
P | |
|---|---|---|---|
| Low | High | ||
|
Age (y) |
|
|
|
| ≤ 45 |
18 (54.5%) |
16 (37.2%) |
0.165 |
| > 45 |
15 (45.5%) |
27 (62.8%) |
|
|
Gender |
|
|
|
| Male |
24 (72.7%) |
31 (72.1%) |
1.01 |
| Female |
9 (27.3%) |
12 (27.9%) |
|
|
Clinical stage |
|
|
|
| I-II |
18 (54.5%) |
6 (14%) |
0.00036 |
| III-IV |
15 (45.5%) |
37 (86.0%) |
|
|
T classification |
|
|
|
| T1-T2 |
22 (66.7%) |
13 (30.4%) |
0.002 |
| T3-T4 |
11 (33.3%) |
30 (69.6%) |
|
|
N classification |
|
|
|
| N0-N1 |
25 (75.8%) |
22 (51.2%) |
0.034 |
| N2-3 |
8 (24.2%) |
21 (48.8%) |
|
|
Metastases |
|
|
|
| No |
33 (100%) |
41 (95.3%) |
0.502 |
| Yes |
0 |
2 (4.7%) |
|
|
Histological classification |
|
|
|
| NKUC |
31 (93.9%) |
43 (100%) |
0.185 |
| NKDC |
2 (6.1%) |
0 |
|
| Fisher’s exact test | |||